Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosign bladder outlet obstruction in patients with benign prostate hyperplasia

Hellenic Journal of Nuclear Medicine

Volumn 10, Issue 2, 2007, Pages 138-143

  Bantis, Athanassios ^a   Zissimopoulos, Athanassios ^b   Kalaytzis, Christos ^b   Giannakopoulos, Telios ^b   Soundoulidis, Petros ^b   Agelonidou, Eleni ^b   Voudalikakis, Chrisostomos ^b   Touloupidis, Stavros ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; BLADDER OBSTRUCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; URINE FLOW RATE; VOLUMETRY;

AGED; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY; URINARY BLADDER DISEASES; URINARY BLADDER NECK OBSTRUCTION;

EID: 34548309376     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Roehrborn CG and McConnell JD. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan EDJ. Wein Ad, editors. Campbell's Urology, 8th edn. Philadelphia, WB Saunders, 2002; 1397-1330.
2. Barry MJ, Fowler FJ, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-1557.
3. Barry MJ, Fowler FJ, O'Leary MP et al. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Asociation. J Urol 1992; 148: 1558-1563.
4. Griffiths D, Hofner K, van Mastrigt R et al. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol Urodyn 1997; 16: 1-8.
5. Chia, SJ, Heng CT, Chan SP et al. Correlation of Intravesical prostatic protrusion with bladder outlet obstruction. BJU Int 2003; 91: 371-374.
6. Yuen J S, Ngiap JT, Cheng CW et al. Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume. Int J Urol 2002; 9: 225-229.
7. Tan YH, Foo KT. Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J Urol 2003; 170: 2339-2341.
8. Cocket AT, Aso Y, Denis L et al. Recommendations of the International Consensus Committee concerning: 1. Prostate symptom score and quality of life assessment. In: Cockett AT, Khoury S, Aso Y et al, editors. Proceedings, The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH), Paris, June 27-30, 1993. Jersey, Channel Islands, Scientific Communication International Ltd, 1994; 553-555.
9. Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty five and seventy nine years of age. Urology 1993; 42: 36-41.
10. Yan JJ, Coplende G, Pefrosja A et al. Effects of rectal examination, prostatic massage, ultrasonography and biopsy on serum prostatic specific antigen levels. J Urol 1992; 147: 810-814.
11. Oesterling JE, Rice DC. The effect of cytoscopy prostatic biopsy and TUR-P on the serum prostate specific antigen concentration. Urology 1998; 146: 375-383.
12. Mochtar CA, Kiemeney LA, van Riemsdijk MM et al. Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia. Eur Urol 2003; 44: 695-700.
13. Roehrborn CG, Boyle P, Gould AL et al. Serum prostate specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 1999; 53: 581-589.
14. Roehrborn CG, McConnell JD, Lieber M et al. Serum prostate specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 1999; 53: 473-80.
15. Laniado ME, Ockrim JL, Marronaro A et al. Serum PSA to predict the presence of bladder outlet obstruction in men with urinary symptoms. BJU Int 2004; 94: 1283-1286.
16. Belal M, Abrams P. Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1 nonurodynamic approach. Urology 2006; 176: 22-28.
17. Glaser AI. Prostate cancer with low PSA levels (C). N Engl J Med 2004, 351: 1802-1803.
18. Thompson IM, Goodman P, Tangen C et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349: 215-221.
19. Petrylak D, Tangen, G, Maha P et al. Doxatel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004; 351: 1513-1520.
20. Grammaticos P. Diagnostic and prognostic value of serum prostate specific antigen in prostate carcinoma. Hell J Nucl Med 2004; 7: 146-147.
21. Ezz EL, Din K, Kiemeney A et al. Correlation between uroflowmetry, prostate volume, postvoid residue and lower urinary tract symptoms as measured by the IPSS. Urology 1996; 48: 393-396.
22. Domochowski R. Bladder outlet obstruction: Etiology and Evaluation. Reviews in Urology 2005; suppl 6: 3-13.
23. Anderson JB, Roehrborn CG, Schalken JA et al. The progression of benign prostatic hyperplasia: examining the evidence and determining the risk. Eur Urol 2001; 39: 390-399.
24. Roehrborn CG, Boyle P, Bergner D et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow-rate: results of four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology 1999; 54: 662-669.
25. Rosier PF, de la Rosette JJ. Is there a correlation between prostate size and bladder-outlet obstruction? World J Urol 1995; 13: 9-13.